{{Rsnum
|rsid=5744080
|Gene=TLR8
|Chromosome=X
|position=12919685
|Orientation=plus
|GMAF=0.367
|Gene_s=TLR8,TLR8-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 53.1 | 23.4 | 23.4
| HCB | 9.1 | 15.9 | 75.0
| JPT | 9.1 | 22.7 | 68.2
| YRI | 11.1 | 12.7 | 76.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 9.1 | 15.9 | 75.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 5.5 | 10.1 | 84.4
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23255072
|Title=Association of a functional polymorphism in the promoter region of TLR-3 with osteoarthritis: A two-stage case-control study
}}

{{PMID Auto
|PMID=19505919
|Title=Toll-like receptor signaling pathway variants and prostate cancer mortality.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}